Liu M#, Yang W#, Guo C#, Liu Z#, Li F, Liu A, Yang H, Shen L, Wu Q, Duan L, Wang H, Tian H, Shi C, Pan Y, Liu Y, Liu F, Weiss NS, Cai H, He Z*, Ke Y. Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial.,J Clin Oncol,2024

Liu Z#, Liu M#, Liu Y#, Zhou R#, Abliz A#, Yuan W, Guo C, Zhang L, He W, Zheng H, Huang Y, Pan Y, Liu F, Hu Z, Chen H, Cai H, He Z*, Ke Y*. Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study,Cell Rep Med,2023;4(9):101168.

Qin J#, Liu M#, Liu A#, Guo C, Qi Z, Zhou R, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.Lugol-unstained lesions location in the esophagus affects the detection rate of malignancy: a population-based study.,J Gastroenterol Hepatol,2023;38(12):2167-2173.

Liu M#, Qi Z#, Zhou R#, Guo C, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.How should extra-large Lugol-unstained lesions of the esophagus be treated? Results from a population-based cohort study.,Cancer Med,2023;12(19):20129-20139.

Qi Z#, Liu M#, Zhou R, Guo C, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Wu N, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.Multiple Lugol-unstained lesions predict higher cumulative risk of malignance in the esophagus.,J Gastroenterol Hepatol,2023.38(3):416-423.

Liu M#, Liu Y#, Zhou R#, Liu Z, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Zhao M, Su H, Liu F, Pan Y, Cai H, He Z*, Ke Y*.Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesions.,J Pathol.,2022.258(1):38-48.

Liu M#, Zhou R#, Liu Z#, Guo C, Xu R, Zhou F, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Zheng H, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, and Ke Y*. Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.,EClinicalMedicine,47:101394.

Liu M#, Zhou R#, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS*, He Z*, Ke Y*. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.,Gastrointest Endosc.,2021.S0016-5107(20)34785-4

Zhou R#, Zheng H#, Liu M#, Liu Z#, Guo C, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, Ke Y*.Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.,Chin J Cancer Res,2021.33(6):649-658.

Wang M#, Liu M#, Guo C, Li F, Liu Z, Pan Y, Liu F, Liu Y, Bao H, Hu Z, Cai H, He Z*, Ke Y*.Association of early-life undernutrition and risk of dyslipidemia in adulthood: a population-based cohort study.,BMC Public Health,2021.21(1):2129.

Wang MM, Guo CH, Li FL, Xu RP, Liu Z, Pan YQ, Liu FF, Liu Y, Cai H, Liu MF*, He ZH, Ke Y*.Family history of esophageal cancer modifies the association of serum lipids and malignant esophageal lesions: a nested case-control study from the "Endoscopic Screening for Esophageal Cancer in China" trial.,Chin Med J (Engl),2021.134(9):1079-1086.

Liu F#, Liu M#, Liu Y#, Guo C, Zhou Y, Li F, Xu R, Liu Z, Deng Q, Li X, Zhang C, Pan Y, Ning T, Dong X, Hu Z, Bao H, Cai H, Silva IDS, He Z*, Ke Y*.Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study.,Chin J Cancer Res,2020.32(6):742-754.

Wang M#, Liu M#, Li F, Guo C, Liu Z, Pan Y, Liu Y, Liu F, Cai H, Wu Y, He Z*, Ke Y*.Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese.,Lipids Health Dis,2020.19(1):135.

Liu M#, Liu Z#, Liu F#, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Cao C, Pan Y, Liu Y, Li J, Cai H, He Z*, Ke Y*.Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.,Clin Gastroenterol Hepatol,2020.18(7):1626-1635.

Shi C#, Liu M#, Liu Z, Guo C, Li F, Xu R, Liu F, Liu Y, Li J, Cai H, He Z*, Ke Y*.Using health insurance reimbursement data to identify incident cancer cases.,J Clin Epidemiol,2019.114:141-149.